Familial Adenomatous Polyposis Clinical Trial
Official title:
Visualization of the Papilla Through Use of the NuView Device in Patients With FAP
The goal of this observational study is to test the NuView device in participants with familial adenomatous polyposis (FAP). The main question it aims to answer is: - can the papilla be visualized using a forward-facing endoscope outfitted with the NuView device. Participants will undergo standard of care esophagogastroduodenoscopy with an additional endoscopic exam using NuView device, for which participant have given prior consent.
The clinical practice at Vanderbilt University Medical Center will first perform the routine upper endoscopic exam with a forward-viewing gastroscope to evaluate the patient's esophagus, stomach, and duodenum. After this has been completed, the forward-viewing endoscope will be removed from the patient and outfitted with the EndoTheia NuView. The endoscope with NuView will then be inserted transorally down the esophagus, traverse the stomach, and be passed into the duodenum for visualization of the papilla. After the papilla is visualized, the endoscope with NuView will be removed from the patient. As per standard of care, the conventional side-viewing endoscope will then be inserted transorally down the esophagus, traverse the stomach, and be passed into the duodenum for visualization of the papilla. The side-viewing endoscope will then be removed from the patient. The Investigators plan to enroll 3 FAP patients who are already scheduled to undergo their standard of care endoscopic exam. The primary endpoint of the study is successful visualization of the papilla with the NuView platform. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05630794 -
Testing ONC201 to Prevent Colorectal Cancer
|
Phase 1 | |
| Completed |
NCT02961374 -
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
|
Phase 2 | |
| Completed |
NCT01483144 -
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
|
Phase 3 | |
| Completed |
NCT00641147 -
Curcumin in Treating Patients With Familial Adenomatous Polyposis
|
Phase 2 | |
| Recruiting |
NCT03471403 -
Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis
|
||
| Not yet recruiting |
NCT04531930 -
Colorectal Adenoma Canceration in FAP
|
||
| Recruiting |
NCT04677998 -
A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
|
||
| Recruiting |
NCT04678011 -
A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
|
||
| Completed |
NCT00927485 -
Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
|
N/A | |
| Recruiting |
NCT00253812 -
Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy
|
N/A | |
| Withdrawn |
NCT00248053 -
Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients
|
Phase 2 | |
| Recruiting |
NCT02012699 -
Integrated Cancer Repository for Cancer Research
|
||
| Completed |
NCT04674228 -
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
|
||
| Completed |
NCT01656746 -
Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease
|
N/A | |
| Completed |
NCT00808743 -
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT03847636 -
CryoBalloon Ablation for Treatment of Duodenal Adenomas
|
N/A | |
| Not yet recruiting |
NCT05112822 -
Testing Obeticholic Acid (OCA) for Familial Adenomatous Polyposis (FAP)
|
Phase 1 | |
| Recruiting |
NCT02656134 -
Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)
|
N/A | |
| Withdrawn |
NCT01245816 -
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
|
Phase 3 | |
| Recruiting |
NCT04709445 -
Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
|
N/A |